Clarifying the 2022 IFSO/ASMBS Metabolic and Bariatric Surgery Guidelines for Asians: Safeguarding Against Misapplication
Author:
Open Access
- 1 September 2025
- journal article
- editorial
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (10) , 4023-4025
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)Obesity Surgery, 2024
- 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric SurgeryObesity Surgery, 2022
- The effect of laparoscopic sleeve gastrectomy on type 2 diabetes remission outcomes in patients with body mass index between 25 kg/m 2 and 32.5 kg/m 2Asian Journal of Surgery, 2021
- Predictors of Type 2 Diabetes Mellitus Remission After Metabolic Surgery in Asian Patients with a BMI < 32.5 kg/m2Obesity Surgery, 2021
- Preoperative predictors of early relapse/no‐remission of type‐2 diabetes after metabolic surgery in Chinese patientsClinical Obesity, 2020
- Short-Term Diabetes Remission Outcomes in Patients with BMI ≤ 30 kg/m2 Following Sleeve GastrectomyObesity Surgery, 2019
- The Predictive Factors for Diabetic Remission in Chinese Patients with BMI > 30 kg/m2 and BMI < 30 kg/m2 Are DifferentObesity Surgery, 2018
- The Recovery of Beta-Cell Function is Critical for Antidiabetic Outcomes of Gastric Bypass in Asian Subjects with Type 2 Diabetes and a Body Mass Index Below 30Obesity Surgery, 2016
- Short-Term Outcomes of Laparoscopic Single Anastomosis Gastric Bypass (LSAGB) for the Treatment of Type 2 Diabetes in Lower BMI (<30 kg/m2) PatientsObesity Surgery, 2014
- Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationshipObesity Reviews, 2002